Package 63323-762-10

Brand: topotecan hydrochloride

Generic: topotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 63323-762-10
Digits Only 6332376210
Product NDC 63323-762
Product ID 63323-762_7f91362f-6b55-4518-b034-b54aa5881204
Description

1 VIAL in 1 BOX (63323-762-10) / 4 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2010-11-30
Brand topotecan hydrochloride
Generic topotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Topotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "7f91362f-6b55-4518-b034-b54aa5881204", "openfda": {"upc": ["0363323762100"], "unii": ["956S425ZCY"], "rxcui": ["1799416"], "spl_set_id": ["b6019088-cd94-43b4-b5ce-ba20b6b8021e"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (63323-762-10)  / 4 mL in 1 VIAL", "package_ndc": "63323-762-10", "marketing_start_date": "20101130"}], "brand_name": "Topotecan Hydrochloride", "product_id": "63323-762_7f91362f-6b55-4518-b034-b54aa5881204", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "63323-762", "generic_name": "TOPOTECAN HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topotecan Hydrochloride", "active_ingredients": [{"name": "TOPOTECAN HYDROCHLORIDE", "strength": "4 mg/4mL"}], "application_number": "ANDA091089", "marketing_category": "ANDA", "marketing_start_date": "20101130", "listing_expiration_date": "20271231"}